Typicality: | 0.393 |
Saliency: | 0.335 |
in conjunction with therapeutic antisense oligonucleodies | 3 | other |
chronically | 2 | manner |
preferably | 2 | manner |
compound → be administered to → patient | 7 |
compound → be administered to → human | 5 |
compound → be administered to → subject | 4 |
negative | neutral | positive |
0.062 | 0.804 | 0.135 |
Raw frequency | 16 |
Normalized frequency | 0.335 |
Modifier score | 0.500 |
Perplexity | 74.806 |